Dermapharm Holding
XTRA:DMP
47,25
€0,00 (0,00%)
47,25
€0,00 (0,00%)
End-of-day quote: 04/03/2026

Quick Analysis
The traffic-light system summarizes key characteristics and shows the investment’s quality at a glance.

€2,56
Earnings Per Share
€21,64
Revenue Per Share
0,00%
Gross Margin %
€2,54 B
Market Cap
€0,89 B
Long-Term Debt
Earnings Per Share
€2,56
Revenue Per Share
€21,64
Gross Margin %
0,00%
Market Cap
€2,54 B
Long-Term Debt
€0,89 B

Financials

Year Year 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017
EPS Earnings Per Share €2,56 €2,19 €1,48 €2,82 €3,94 €1,80 €1,49 €1,46 €0,46
Earnings Earnings €137,83M €117,91M €79,68M €151,83M €212,13M €96,91M €80,22M €78,61M €23,00M
RPS Revenue Per Share €0,00 €21,64 €21,93 €21,09 €19,03 €17,51 €14,74 €13,02 €10,63 €9,34
Revenue Revenue €0,00M €1,16B €1,18B €1,14B €1,02B €942,91M €793,83M €700,88M €572,42M €467,00M
OCF Operating Cash Flow €0,00M €188,10M €201,38M €219,42M €288,53M €250,37M €131,10M €100,61M €159,13M €86,74M
FCF Free Cash Flow €0,00M €144,95M €163,14M €177,88M €249,52M €189,17M €90,30M €-281,54M €133,16M €12,02M
OM Operating Margin 0,00% 0,00% 18,58% 16,79% 27,17% 30,82% 17,34% 16,86% 19,29% 18,70%
GM % Gross Margin % 0,00% 0,00% 62,73% 61,19% 62,34% 63,56% 56,15% 52,83% 50,48% 45,70%
FCFS Free Cash Flow Per Share €0,00 €0,00 €3,03 €3,30 €4,63 €3,51 €1,68 €1,01 €2,49 €0,24
LT Debt Long-Term Debt N/A €886,71M €886,71M €963,89M €501,84M €565,71M €570,48M €533,59M €232,55M €222,35M
Sha. Stocks 53,84M 53,84M 53,84M 53,84M 53,84M 53,84M 53,84M 53,84M 53,84M 50M
×